CN101357189B - Traditional Chinese medicine composition for treating atrophic gastritis - Google Patents
Traditional Chinese medicine composition for treating atrophic gastritis Download PDFInfo
- Publication number
- CN101357189B CN101357189B CN2008101394096A CN200810139409A CN101357189B CN 101357189 B CN101357189 B CN 101357189B CN 2008101394096 A CN2008101394096 A CN 2008101394096A CN 200810139409 A CN200810139409 A CN 200810139409A CN 101357189 B CN101357189 B CN 101357189B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- atrophic gastritis
- portions
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a traditional Chinese medicine compound used for treating atrophic gastritis, which is made of 2-4 portions of enoxolone, 1-3 portions of bletilla tuber, 1-2 portions of fritillary bulb, 2-4 portions of cuttlebone, 2-4 portions of corydalis tuber and 4-6 portions of bistort rhizome powder. The compound has relatively obvious effect on treating the atrophic gastritis.
Description
Technical field the present invention relates to a kind of Chinese medicine for the treatment of gastritis, particularly a kind of Chinese medicine composition for the treatment of atrophic gastritis.
The background technology atrophic gastritis is common, the frequently-occurring disease kind among the crowd, and it causes that digestive function descends, acid regurgitation, and pain, serious meeting causes hemorrhage, perforation, crisis life.Existing Chinese medicine preparation prescription is complicated, the cost height, and curative effect is not obvious.
Summary of the invention technical problem to be solved by this invention is, a kind of Chinese medicine composition for the treatment of atrophic gastritis is provided, and by selecting suitable Chinese medicine and consumption proportion thereof, reaches the significant purpose of therapeutic effect.To overcome the defective of prior art.
In order to solve the problems of the technologies described above, the present invention has adopted following technical scheme:
A kind of Chinese medicine composition for the treatment of atrophic gastritis is characterized in that: enoxolone 2-4 part, and Pseudobulbus Bletillae (Rhizoma Bletillae) 1-3 part, Bulbus Fritillariae Thunbergii 1-2 part, Endoconcha Sepiae 2-4 part, Rhizoma Corydalis 2-4 part, Herba Salviae Chinensis powder 4-6 part is formulated; Described part refers to weight portion.
Preferred prescription is: 3 parts of enoxolone, 2 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 1.5 parts of Bulbus Fritillariae Thunbergiis, 3 parts of Endoconcha Sepiaes, 3 parts of Rhizoma Corydalis, 5 parts in Herba Salviae Chinensis powder.
Chinese herbal medicine of the present invention is according to traditional medicine and modern medicine analysis, and the property of medicine and pharmacological action are as follows.
The pharmacological action of enoxolone:
The effect of adrenocortical hormone sample: the effect of desoxycortone sample is arranged, the discharge of kinds of experiments animal urine amount and sodium is reduced, potassium is discharged to be increased, and blood sodium rises, and blood calcium reduces, the coccoid band atrophy of adrenal cortex; Cortisone can increase its effect in a small amount.The antiinflammatory antiallergic action: cotton balls granulation, formaldehyde edema, tuberculin reaction, subcutaneous granulation capsule inflammation, carrageenin edema to Mus all have inhibitory action, can influence the phase of oozing out and the proliferative phase of subcutaneous granulation cyst inflammation effectively, its antiinflammatory intensity is weaker than or is bordering on cortisone.Its hydrochlorate still can suppress capillary permeability.Guinea pig trachea spasm due to the protein is not then had preventive effect, but can suppress the influence of histamine vascular permeability.
Pseudobulbus Bletillae (Rhizoma Bletillae): meridian distribution of property and flavor: bitter sweet puckery, be slightly cold.Go into lung, liver, stomach warp.Function cures mainly: astringing to arrest bleeding, detumescence and promoting granulation.Be used for the lung gastrorrhagia, traumatic hemorrhage, carbuncle, burst cancer, rhagadia manus et pedis.
Bulbus Fritillariae Thunbergii: meridian distribution of property and flavor: cold; Bitter; Return lung, heart channel.Function cures mainly: heat clearing away eliminating stagnation, preventing phlegm from forming and stopping coughing.Be used for wind-heat invading the lung, phlegm-fire cough, lung abscess, acute mastitis, scrofula, sore.
Endoconcha Sepiae: meridian distribution of property and flavor: tepor; Salty, puckery; Return liver, kidney channel.Function cures mainly: astringing to arrest bleeding, and relieving leukorrhea by astringents, skin ulcer is held back in antacid.Be used to the acid regurgitation of having a stomachache, hematemesis and epistaxis, metrorrhagia is had blood in stool, emission and spermatorrhea, leucorrhea with red and white discharge; Peptic Ulcers.The external treatment bleeding due to trauma, the many pus of skin ulcer.
Rhizoma Corydalis: meridian distribution of property and flavor: temperature; Hot, bitter; Return liver, spleen channel.Function cures mainly: invigorate blood circulation promoting the circulation of QI, pain relieving.Be used for the breast side of body, wrist abdomen pain, amenorrhea dysmenorrhea, postpartum stagnation, tumbling and swelling.
Herba Salviae Chinensis powder: meridian distribution of property and flavor: be slightly cold; Bitter, puckery; Return liver, liver, large intestine channel.Function cures mainly: heat-clearing and toxic substances removing, detumescence, hemostasis.Be used for bloody dysentery, diarrhea of heat type, cough due to lung-heat, carbuncle, scrofula.
The present invention sheerly prepared from traditional Chinese medicines forms, and is a kind of Chinese medicine for oral administration.Pain relieving, emesis, antiacid, hemostasis are arranged, promote ulcer surface healing effect, the effect of treatment digestive tract ulcer disease is apparent in view.
The specific embodiment further specifies the present invention in order to understand better and to implement below in conjunction with embodiment.
Embodiment one
2 parts of extracting liquorice subacids, 1 part of Pseudobulbus Bletillae (Rhizoma Bletillae), 1 part of Bulbus Fritillariae Thunbergii, 2 parts of Endoconcha Sepiaes, 2 parts of Rhizoma Corydalis, 4 parts of mixed powders of Herba Salviae Chinensis powder are broken into the end, incapsulate.Day clothes 3 times, one time 2,2-3 week can fully recover.
Embodiment two
3 parts of extracting liquorice subacids, 2 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 1.5 parts of Bulbus Fritillariae Thunbergiis, 3 parts of Endoconcha Sepiaes, 3 parts of Rhizoma Corydalis, 5 parts of mixed powders of Herba Salviae Chinensis powder are broken into the end, incapsulate.Day clothes 3 times, one time 2,2-3 week can fully recover.
Embodiment three
4 parts of extracting liquorice subacids, 3 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 2 parts of Bulbus Fritillariae Thunbergiis, 4 parts of Endoconcha Sepiaes, 4 parts of Rhizoma Corydalis, 6 parts of mixed powders of Herba Salviae Chinensis powder are broken into the end, incapsulate.Day clothes 3 times, one time 2,2-3 week can fully recover.
It below is clinical use curative effect situation.
With medicine treatment atrophic gastritis 98 examples of the present invention, the result shows medicine group obvious effective rate 91% of the present invention, total effective rate 99%.
Claims (2)
1. Chinese medicine composition for the treatment of atrophic gastritis is characterized in that: enoxolone 2-4 part, and Pseudobulbus Bletillae (Rhizoma Bletillae) 1-3 part, Bulbus Fritillariae Thunbergii 1-2 part, Endoconcha Sepiae 2-4 part, Rhizoma Corydalis 2-4 part, Herba Salviae Chinensis powder 4-6 part is made.
2. the Chinese medicine composition of treatment atrophic gastritis as claimed in claim 1 is characterized in that: 3 parts of enoxolone, and 2 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 1.5 parts of Bulbus Fritillariae Thunbergiis, 3 parts of Endoconcha Sepiaes, 3 parts of Rhizoma Corydalis, the Herba Salviae Chinensis powder is made for 5 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101394096A CN101357189B (en) | 2008-09-02 | 2008-09-02 | Traditional Chinese medicine composition for treating atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101394096A CN101357189B (en) | 2008-09-02 | 2008-09-02 | Traditional Chinese medicine composition for treating atrophic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101357189A CN101357189A (en) | 2009-02-04 |
| CN101357189B true CN101357189B (en) | 2011-04-06 |
Family
ID=40329875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101394096A Expired - Fee Related CN101357189B (en) | 2008-09-02 | 2008-09-02 | Traditional Chinese medicine composition for treating atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101357189B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103127370A (en) * | 2013-03-05 | 2013-06-05 | 李创球 | Dandelion granule |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101066445A (en) * | 2007-06-29 | 2007-11-07 | 曹国胜 | Chinese medicine prepn for curing gastropathy radically |
-
2008
- 2008-09-02 CN CN2008101394096A patent/CN101357189B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101066445A (en) * | 2007-06-29 | 2007-11-07 | 曹国胜 | Chinese medicine prepn for curing gastropathy radically |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103127370A (en) * | 2013-03-05 | 2013-06-05 | 李创球 | Dandelion granule |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101357189A (en) | 2009-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6916494B2 (en) | Anti-hemorrhoid composition and process for its manufacture | |
| CN106729669A (en) | A kind of medicinal external emulsifiable paste for treating nettle rash | |
| CN101357189B (en) | Traditional Chinese medicine composition for treating atrophic gastritis | |
| CN104771567A (en) | Alcohol-effect-dispelling pharmaceutical composition | |
| CN108392580A (en) | A kind of feed addictive and preparation method thereof of prevention chicken coccidiasis | |
| CN103735695A (en) | Chinese medicine composition for treating urinary tract infection and preparation method thereof | |
| CN101496884B (en) | Capsule for treating gastric precancerous lesion | |
| CN110898137A (en) | Pills for treating hyperthyroidism and preparation method and application thereof | |
| CN103816413A (en) | Traditional Chinese medicinal preparation for treating postoperative pneumonia | |
| CN102335294B (en) | Chinese medicinal herb decoction for treating thrombocytopenia after radio-chemotherapy | |
| CN102961444A (en) | Compound preparation for treating rhinosinusitis | |
| CN107468878A (en) | A kind of Chinese medicine composition for treating canker sore | |
| CN101897883A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN1191071C (en) | Product of ginsenoside for improving sextual function | |
| CN106491843B (en) | A kind of Chinese medicine for treating cholecystolithiasis, kidney stone, vesical calculus | |
| CN105412766A (en) | Pharmaceutical composition for treating chronic diarrhea | |
| CN105288305A (en) | Pharmaceutical composition for curing oral excessive inflammation and gingival pain and swelling and preparation method of pharmaceutical composition | |
| CN106668353A (en) | Hui nationality traditional Chinese medicinal scorpion breast cancer treatment granule and preparation method thereof | |
| CN104547922A (en) | Chinese medicinal composition for treating prostatitis and preparation method thereof | |
| CN104815177A (en) | Traditional Chinese medicine for treating asthma of children | |
| CN104435832A (en) | Traditional Chinese drug composition for treating primary thrombocythemia | |
| CN105613815A (en) | Preparation method of albizia julibrissin black tea | |
| CN110742936A (en) | Traditional Chinese medicine for treating gastrorrhagia and preparation method thereof | |
| CN113876744A (en) | Sanfu plaster for treating chronic bronchitis and preparation method thereof | |
| CN110898133A (en) | External traditional Chinese medicine ointment for treating haemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Zhihong Inventor after: Dong Guoying Inventor after: Tan Yongfang Inventor after: Liang Lixiang Inventor before: Liang Lixiang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIANG LIXIANG TO: WANG ZHIHONG DONG GUOYING TAN YONGFANG LIANG LIXIANG |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HANGZHOU WANCHENGZHITANG CHINESE MEDICINE CO., LTD Free format text: FORMER OWNER: LIANG LIXIANG Effective date: 20120202 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264003 YANTAI, SHANDONG PROVINCE TO: 310002 HANGZHOU, ZHEJIANG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120202 Address after: 5037, room 310002, Wu Shan building, 9 Yanan Road, Zhejiang, Hangzhou Patentee after: HANGZHOU WANCHENGZHITANG TRADITIONAL CHINESE MEDICINE Co.,Ltd. Address before: 264003 Shandong Province, Yantai city Laishan District Yingchun Street No. 133 Patentee before: Liang Lixiang |
|
| ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG WANCHENGZHITANG TRADITIONAL CHINESE MEDIC Free format text: FORMER OWNER: HANGZHOU WANCHENGZHITANG CHINESE MEDICINE CO., LTD. Effective date: 20140514 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20140514 Address after: Gaoyin street Hangzhou city Zhejiang province 310002 No. 103 Patentee after: Zhejiang Wan Chengzhi Tang Chinese medicine health management Limited by Share Ltd. Address before: 5037, room 310002, Wu Shan building, 9 Yanan Road, Zhejiang, Hangzhou Patentee before: HANGZHOU WANCHENGZHITANG TRADITIONAL CHINESE MEDICINE Co.,Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Fang Zheming Document name: Notification of Passing Examination on Formalities |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Gaoyin street Hangzhou city Zhejiang province 310002 No. 103 Patentee after: Dacheng medical investment Limited by Share Ltd. Address before: Gaoyin street Hangzhou city Zhejiang province 310002 No. 103 Patentee before: Zhejiang Wan Chengzhi Tang Chinese medicine health management Limited by Share Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110406 Termination date: 20210902 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |